Analysts/Institutional Investor Meet/Con. Call Updates

Gland Pharma Limited has informed the exchanges about a scheduled one-on-one meeting with institutional investor Ambit PMSS, arranged by B&K / 360One. This meeting is slated for June 25, 2026, as a routine engagement with the investment community. The announcement is a procedural disclosure of an investor interaction, with no specific agenda or material information disclosed at this stage. Such meetings are a standard part of investor relations.